Ixekizumab-treatment-emergent photosensitive cutaneous eruption
Eleni Anthony, Harini Rajgopal Bala, Michelle SY Goh, Showan Balta, Peter Foley
Australasian Journal of Dermatology | WILEY | Published : 2018
P. Foley has served as a consultant, investigator, speaker or advisor for, and/or received travel grants from Abbott AbbVie, Amgen, Bristol-Myers-Squibb, Boehringer Ingelheim, Celgene, Celtaxsys, Cutanea, Dermira, Galderma, Genentech, GSK, Stiefel, Janssen, Leo Pharma, Lilly, Novartis, Regeneron Pharmaceuticals, Inc., Roche, Sanofi, Schering-Plough and Merck, 3M, iNova and Valeant, Sun Pharmaceuticals, UCB Pharma and Wyeth Pfizer. There are no conflicts of interest for the other authors.